Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure

Evidence for cardiovascular outcomes with older-generation antihyperglycemic drugs in the management of type 2 diabetes is based on aggregated data from prior randomized controlled trials and observational studies that were not focused on prespecified cardiovascular end points. Newer antihyperglycem...

Description complète

Détails bibliographiques

Auteurs principaux:	Khawaja M. Talha, Gregg C. Fonarow, Salim S. Virani, Javed Butler
Format:	Artigo
Langue:	Inglês
Publié:	Houston Methodist DeBakey Heart & Vascular Center 2022-12-01
Collection:	Methodist DeBakey Cardiovascular Journal
Sujets:	sodium-glucose cotransporter-2 inhibitor glucagon-like peptide 1 receptor agonist heart failure cardiovascular disease prevention
Accès en ligne:	https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1155
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!